Bordetella pertussis vaccine strains and circulating isolates in Serbia

Gordana Dakic1, Teemu Kallonen, Annika Elomaa

  • 1Institute of Virology, Vaccine and Sera Torlak, Belgrade, Serbia.

Vaccine
|December 1, 2009
PubMed

Insights

Serbian Bordetella pertussis strains show genetic differences from other vaccinated populations. These variations in pertussis toxin (ptxA) and pertactin (prn) alleles may be linked to the specific whole cell pertussis vaccine composition used since 1985.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Serbia has utilized a whole cell pertussis vaccine since 1957, with its current formulation established in 1985.
  • The vaccine contains four autochthonous Bordetella pertussis strains isolated between 1957 and 1984.

Observation:

  • A study analyzed 70 Bordetella pertussis isolates (1953-2000) and vaccine strains using serotyping, genotyping (ptxA, prn), and pulsed-field gel electrophoresis.
  • Genetic shifts were observed, including a move from ptxA2 to ptxA1 alleles in the late 1960s, with ptxA1 predominant by 1980-1984.
  • The re-emergence of ptxA2 followed the 1985 vaccine update introducing ptxA1 strains.
  • prn1 was the dominant allele, with prn3 and prn11 appearing later, and prn2 detected only in 2000.
  • Fimbrial serotype Fim2.3 vanished before 1980, with Fim2 becoming predominant.

Findings:

  • Serbian Bordetella pertussis isolates exhibit distinct genetic profiles compared to those in other vaccinated populations.
  • Significant variations were noted in the ptxA and prn alleles between the Serbian vaccine strains and the studied isolates.
  • The observed genetic changes in Bordetella pertussis correlate with the vaccine's historical composition and introduction timeline.

Implications:

  • The unique genetic characteristics of Serbian Bordetella pertussis strains may necessitate tailored vaccine strategies or monitoring.
  • Understanding these population dynamics is crucial for evaluating vaccine effectiveness and guiding future pertussis vaccine development.
  • The study highlights the potential impact of vaccine strain selection on the evolution of circulating bacterial populations.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...